Reply to the Letter to the Editor: "Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 vaccine" by Francavilla B et al.: Lack of a strong oral mucosal immune response: rethinking the route of COVID-19 vaccine boost administration?

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
    • Publication Information:
      Original Publication: [Amsterdam] : Elsevier B.V., [2014]-
    • Subject Terms:
      COVID-19*/prevention & control ; COVID-19 Vaccines*; BNT162 Vaccine ; Humans ; Immunity, Mucosal ; RNA, Messenger
    • Abstract:
      Competing Interests: Declaration of interests The authors declare no conflict of interest.
    • Comments:
      Comment on: EBioMedicine. 2022 May;79:104006. (PMID: 35430452)
    • References:
      Pathog Immun. 2021 Jun 7;6(1):116-134. (PMID: 34136730)
      EBioMedicine. 2022 Jan;75:103788. (PMID: 34954658)
      EBioMedicine. 2022 Feb;76:103841. (PMID: 35085851)
      EBioMedicine. 2022 May;79:104006. (PMID: 35430452)
    • Accession Number:
      0 (COVID-19 Vaccines)
      0 (RNA, Messenger)
      N38TVC63NU (BNT162 Vaccine)
    • Publication Date:
      Date Created: 20220418 Date Completed: 20220517 Latest Revision: 20220716
    • Publication Date:
      20221213
    • Accession Number:
      PMC9010772
    • Accession Number:
      10.1016/j.ebiom.2022.104005
    • Accession Number:
      35436727